Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 239

Results For "CENT"

4467 News Found

Kokilaben Dhirubhai Ambani Hospital luanches India's first of its kind advanced Digital PET-CT scanner
Medical Device | September 08, 2023

Kokilaben Dhirubhai Ambani Hospital luanches India's first of its kind advanced Digital PET-CT scanner

The state-of-the-art digital PETCT imaging system, highlights a significant advancement in the fight against cancer and detects other lesions offering patient centric services


Biocon Biologics completes integration of Viatris Biosimilars’ business in North America
News | September 07, 2023

Biocon Biologics completes integration of Viatris Biosimilars’ business in North America

Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris


Apollo Hospitals joins MediSage to host Uro-Oncology symposium
News | September 07, 2023

Apollo Hospitals joins MediSage to host Uro-Oncology symposium

Our collaboration with MediSage to present 'Current Approaches to Uro-Oncology' embodies a crucial stride towards comprehensive cancer care


New tools of diagnosis and therapeutic medicine require holistic approach for desired optimum results, says Dr Jinetdar Singh
Policy | September 06, 2023

New tools of diagnosis and therapeutic medicine require holistic approach for desired optimum results, says Dr Jinetdar Singh

Dr Jitendra Singh launches API Chapter of AFMC, Pune; inaugurates the first annual conference of API-AFMS Continuing Medical Education (CME) on “Emerging trends in the practice of Medicine”


Apollo introduces India's first comprehensive Connected Care Services
Healthcare | September 05, 2023

Apollo introduces India's first comprehensive Connected Care Services

This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition


Amgen settles with FTC over US$28 billion deal
Policy | September 04, 2023

Amgen settles with FTC over US$28 billion deal

Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products


BioNTech to lead $2 billion mRNA-based oncology therapy market despite challenges, says GlobalData
News | September 03, 2023

BioNTech to lead $2 billion mRNA-based oncology therapy market despite challenges, says GlobalData

BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials


Loop's health assurance model drives 200% YoY premium surge across 1000 companies
Healthcare | September 02, 2023

Loop's health assurance model drives 200% YoY premium surge across 1000 companies

Health Assurance is a unique healthcare model that combines health insurance with preventive healthcare with a focus on keeping people healthy while providing sick care for them when needed


USFDA delegation visits Amneal Pharmaceutical facility in Matoda
News | September 02, 2023

USFDA delegation visits Amneal Pharmaceutical facility in Matoda

Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities